Advertisement

An Assessment of Cancer Education Needs to Promote Mid-Adult HPV Vaccination Among Male Sexual Minorities

  • Christopher W. WheldonEmail author
  • Sarah B. Maness
Article

Abstract

The purpose of this study was to assess behavioral expectations and related psychosocial factors regarding an age-expanded human papillomavirus (HPV) vaccine schedule among male sexual minorities (MSM). A measure of behavioral expectation (BE) (“How likely are you to get the HPV vaccine if the CDC recommendation was changed to include men older than 26?”) was evaluated on an ethnoracially diverse sample (N = 318) of MSM. Sixty-seven percent would likely initiate vaccination if the recommendations change. Benefits of HPV vaccination were widely endorsed. Barriers/harms of vaccination were endorsed less frequently. Only 15.4% were concerned that the vaccine would not be effective. The main driver of BE was perceived physical benefits (R2 = 0.34). Psychological benefits were independently associated with BE but did not improve the explanatory model. Expectation of HPV vaccination is high among MSM in the expanded age range. Prevention of anogenital warts and anal cancer is an important consideration for this population; however, promoting the benefits of vaccination must be done in accordance with realistic expectations of vaccine efficacy in older sexually active MSM.

Keywords

HPV vaccination Special populations Older adults Males 

Notes

References

  1. 1.
    Machalek D, Grulich AE, Jin Fengyi J et al (2012) The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men. Sex Health 9:527–537CrossRefGoogle Scholar
  2. 2.
    Daling JR, Weiss NS, Hislop TG et al (1987) Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 317:973–977CrossRefGoogle Scholar
  3. 3.
    Centers for Disease Control and Prevention (2011) Recommendations on the use of quadrivalent human papillomavirus vaccine in males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 60:1705–1708Google Scholar
  4. 4.
    Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (2019) Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 68:698–702CrossRefGoogle Scholar
  5. 5.
    Chesson HW, Ekwueme DU, Saraiya M et al (2011) The cost-effectiveness of male HPV vaccination in the United States. Vaccine.  https://doi.org/10.1016/j.vaccine.2011.07.096 CrossRefGoogle Scholar
  6. 6.
    Oliver SE, Hoots BE, Paz-Bailey G, Markowitz LE, Meites E, NHBS Study Group (2017) Increasing human papillomavirus vaccine coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2014. JAIDS J Acquir Immune Defic Syndr 75:S370–S374.  https://doi.org/10.1097/QAI.0000000000001413 CrossRefPubMedGoogle Scholar
  7. 7.
    Wheldon CW, Sutton SK, Fontenot HB, Quinn GP, Giuliano AR, Vadaparampil ST (2018) Physician communication practices as a barrier to risk-based HPV vaccine uptake among men who have sex with men. J Cancer Educ 33:1126–1131CrossRefGoogle Scholar
  8. 8.
    Wheldon CW, Krakow M, Thompson EL, Moser RP (2019) National trends in human papillomavirus awareness and knowledge of human papillomavirus–related cancers. Am J Prev Med 000:5–11.  https://doi.org/10.1016/j.amepre.2018.11.005 CrossRefGoogle Scholar
  9. 9.
    Gerend MA, Madkins K, Phillips GI, Mustanski B (2016) Predictors of human papillomavirus vaccination among young men who have sex with men. Sex Transm Dis 43:185–191.  https://doi.org/10.1097/OLQ.0000000000000408 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Wheldon CW, Daley EM, Buhi ER et al (2015) HPV vaccine decision-making among young gay and bisexual men. Health Educ J 76:1–14Google Scholar
  11. 11.
    Rahman S, Campbell CMP, Rollison DE et al (2016) Seroprevalence and associated factors of 9-valent human papillomavirus (HPV) types among men in the multinational him study. PLoS One 11:1–16.  https://doi.org/10.1371/journal.pone.0167173 CrossRefGoogle Scholar
  12. 12.
    Wheldon CW, Daley EM, Walsh-Buhi ER, Baldwin JA, Nyitray AG, Giuliano AR (2018) An integrative theoretical framework for HPV vaccine promotion among male sexual minorities. Am J Mens Health 12:1409–1420CrossRefGoogle Scholar
  13. 13.
    Warshaw PR, Davis FD (1985) Disentangling behavioral intention and behavioral expectation. J Exp Soc Psychol 21:213–228CrossRefGoogle Scholar
  14. 14.
    Radisic G, Chapman J, Flight I, Wilson C (2017) Factors associated with parents’ attitudes to the HPV vaccination of their adolescent sons: A systematic review. Prev Med (Baltim) 95:26–37.  https://doi.org/10.1016/j.ypmed.2016.11.019 CrossRefGoogle Scholar
  15. 15.
    Nadarzynski T, Smith H, Richardson D, Jones CJ, Llewellyn CD (2014) Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review. Sex Transm Infect 90:515–523CrossRefGoogle Scholar

Copyright information

© American Association for Cancer Education 2019

Authors and Affiliations

  1. 1.Department of Social and Behavioral Sciences, College of Public HealthTemple UniversityPhiladelphiaUSA
  2. 2.Department of Health and Exercise ScienceUniversity of OklahomaNormanUSA

Personalised recommendations